Have a feature idea you'd love to see implemented?
Let us know!
GHRS GH Research PLC
Price (delayed)
$7.5
Market cap
$390.21M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.67
Enterprise value
$303.84M
gh research is a privately-held clinical-stage biopharmaceutical company developing novel therapies for the management of mental illness.
Highlights
GH Research's debt has decreased by 24% YoY and by 15% QoQ
GH Research's net income has decreased by 8% from the previous quarter but it has increased by 2% YoY
GHRS's EPS is down by 8% since the previous quarter but it is up by 2.9% year-on-year
The quick ratio fell by 23% YoY and by 11% QoQ
GH Research's equity has decreased by 15% YoY and by 5% QoQ
Key stats
What are the main financial stats of GHRS
Market
Valuations
Earnings
Shares outstanding
52.03M
Market cap
$390.21M
Enterprise value
$303.84M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.96
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$34.24M
EBITDA
-$33.92M
Free cash flow
-$43.22M
Per share
Balance sheet
Liquidity
EPS
-$0.67
Free cash flow per share
-$0.83
Book value per share
$3.82
Revenue per share
$0
TBVPS
$3.98
Total assets
$206.98M
Total liabilities
$8.3M
Debt
$760,000
Equity
$198.68M
Working capital
$145.11M
Debt to equity
0
Current ratio
19.6
Quick ratio
19.39
Net debt/EBITDA
2.55
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-15.8%
Return on equity
-16.4%
Return on invested capital
-25.9%
Return on capital employed
-17.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GHRS stock price
How has the GH Research stock price performed over time
Intraday
-9.64%
1 week
-3.1%
1 month
7.3%
1 year
8.54%
YTD
29.31%
QTD
12.11%
Financial performance
How have GH Research's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$45.63M
Net income
-$34.97M
Gross margin
N/A
Net margin
N/A
GH Research's operating income has decreased by 26% YoY and by 8% from the previous quarter
GH Research's net income has decreased by 8% from the previous quarter but it has increased by 2% YoY
Growth
What is GH Research's growth rate over time
Valuation
What is GH Research stock price valuation
P/E
N/A
P/B
1.96
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GHRS's EPS is down by 8% since the previous quarter but it is up by 2.9% year-on-year
GH Research's equity has decreased by 15% YoY and by 5% QoQ
The price to book (P/B) is 6% less than the last 4 quarters average of 2.3
Efficiency
How efficient is GH Research business performance
GHRS's return on invested capital is up by 34% year-on-year but it is down by 14% since the previous quarter
GHRS's return on equity is down by 13% year-on-year and by 12% since the previous quarter
The return on assets has declined by 12% since the previous quarter and by 11% year-on-year
Dividends
What is GHRS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GHRS.
Financial health
How did GH Research financials performed over time
The quick ratio fell by 23% YoY and by 11% QoQ
GHRS's current ratio is down by 23% year-on-year and by 11% since the previous quarter
GH Research's debt is 100% lower than its equity
GH Research's debt has decreased by 24% YoY and by 15% QoQ
GH Research's equity has decreased by 15% YoY and by 5% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.